Recent Advances in Bronchiectasis Treatment: Novel Therapeutic Approaches and Management Strategies
*Corresponding Author: Pujaa Sharma, Department of Epidemiology, College of Public Health, University of Kentucky, U.S.A, Email: psharma36@gmail.comReceived Date: Oct 01, 2024 / Published Date: Oct 31, 2024
Citation: Pujaa S (2024) Recent Advances in Bronchiectasis Treatment: NovelTherapeutic Approaches and Management Strategies. J Pulm Res Dis 8: 225.
Copyright: © 2024 Pujaa S. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Abstract
Bronchiectasis is a chronic pulmonary disease characterized by irreversible dilatation of the bronchi, resulting in persistent symptoms such as chronic cough, sputum production, and recurrent respiratory infections. While treatment traditionally focuses on symptom management, recent advances in the understanding of its pathophysiology have led to the development of novel therapeutic approaches. This article reviews the current state of bronchiectasis treatment, including advancements in pharmacologic therapy, non-pharmacologic interventions, and emerging treatment strategies aimed at improving quality of life and reducing disease exacerbations. By examining the latest research and clinical trial findings, we explore how personalized treatment plans, targeted therapies, and a multidisciplinary approach are shaping the future of bronchiectasis management.
